Pfizer CEO warns German investment at risk over drug pricing policies
By Maggie Fick, Bhanvi Satija and Patricia Weiss LONDON/FRANKFURT, June 10 (Reuters) – Pfizer is reviewing the timing and scope of planned investments in Germany, CEO Albert Bourla said in a letter to Chancellor Friedrich Merz, citing the government’s policy proposals that would lower drug prices. The letter, dated June 9 and seen by Reuters on Wednesday, was first reported by German business newspaper Handelsblatt. Bourla wrote that the proposals […]